A detailed history of Janus Henderson Group PLC transactions in Xencor Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 23,986 shares of XNCR stock, worth $606,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,986
Previous 23,986 -0.0%
Holding current value
$606,845
Previous $454,000 6.17%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$18.21 - $24.5 $5,590 - $7,521
-307 Reduced 1.26%
23,986 $454,000
Q1 2024

May 15, 2024

BUY
$18.65 - $26.52 $55 - $79
3 Added 0.01%
24,293 $537,000
Q4 2023

Feb 14, 2024

SELL
$16.53 - $21.42 $793 - $1,028
-48 Reduced 0.2%
24,290 $515,000
Q3 2023

Nov 14, 2023

BUY
$20.08 - $25.39 $60 - $76
3 Added 0.01%
24,338 $490,000
Q2 2023

Aug 14, 2023

SELL
$24.77 - $29.9 $866 - $1,046
-35 Reduced 0.14%
24,335 $607,000
Q1 2023

May 15, 2023

BUY
$25.95 - $36.95 $356,345 - $507,397
13,732 Added 129.08%
24,370 $679,000
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $615 - $811
25 Added 0.24%
10,638 $277,000
Q2 2022

Aug 15, 2022

SELL
$19.74 - $29.01 $276 - $406
-14 Reduced 0.13%
10,613 $291,000
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $53 - $83
2 Added 0.02%
10,627 $284,000
Q4 2021

Feb 14, 2022

BUY
$33.67 - $43.44 $357,743 - $461,550
10,625 New
10,625 $426,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.51B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.